Lactose (India) Peer Comparison
BSE: 524202
₹108.95
₹1.85
(1.73%)
As on 01-Oct-2026 10:32IST
Market cap
₹135 Cr
Revenue (TTM)
₹171 Cr
P/E Ratio
19.5
P/B Ratio
2
Div. Yield
0 %
Edit
| Lactose (India) | Wockhardt | Piramal Pharma | Rubicon Research | Acutaas Chemicals | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
135 | 34,375 | 27,466 | 26,764 | 26,847 |
Revenue (₹ Cr) |
171 | 3,564 | 9,205 | 1,936 | 1,462 |
Net Profit (₹ Cr) |
6.93 | 414.00 | -371.81 | 288.22 | 387.35 |
Net Margin (%) |
4.02 | 11.23 | -3.93 | 14.79 | 26.01 |
RoE (%) |
10.89 | 8.38 | -3.85 | 29.77 | 25.18 |
Price to Earnings |
19.46 | 84.05 | -- | 92.86 | 69.51 |
Price-To-Book |
2.01 | 6.83 | 3.43 | 19.94 | 15.56 |
Income Statement (₹ Cr)
| Lactose (India) | Wockhardt | Piramal Pharma | Rubicon Research | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Operating Revenue
|
170.68 | 3,564.00 | 9,205.28 | 1,935.80 | 1,461.80 |
|
Total Income
|
172.46 | 3,686.00 | 9,449.59 | 1,948.58 | 1,489.25 |
|
Total Expenditure
|
151.26 | 2,792.00 | 8,195.15 | 1,485.56 | 919.25 |
|
EBITDA
|
19.42 | 772.00 | 1,010.13 | 450.24 | 542.56 |
|
Depreciation
|
6.01 | 226.00 | 857.51 | 50.83 | 37.68 |
|
EBIT
|
13.41 | 546.00 | 152.62 | 399.41 | 504.88 |
|
Interest
|
5.63 | 217.00 | 342.73 | 40.84 | 3.77 |
|
Other Income
|
1.78 | 122.00 | 244.31 | 12.78 | 27.45 |
|
Exceptional Items
|
0.00 | 12.00 | -216.88 | 0.00 | 0.00 |
|
Profit before Tax
|
9.56 | 463.00 | -162.68 | 371.35 | 528.56 |
|
Provision for Tax
|
2.64 | 49.00 | 209.13 | 83.14 | 141.21 |
|
Profit after Tax
|
6.93 | 414.00 | -371.81 | 288.22 | 387.35 |
Liabilities (₹ Cr)
| Lactose (India) | Wockhardt | Piramal Pharma | Rubicon Research | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
64.79 | 4,940.00 | 8,162.62 | 1,288.82 | 1,653.56 |
|
Minority Interest
|
0.00 | -5.00 | 0.00 | 0.00 | -1.13 |
|
Non-Current Liabilities
|
28.64 | 1,712.00 | 5,044.14 | 202.03 | 42.40 |
|
Current Liabilities
|
89.80 | 1,622.00 | 4,758.28 | 835.87 | 230.82 |
|
Total Liabilities
|
133.47 | 8,100.00 | 15,513.53 | 1,451.43 | 1,549.26 |
Assets (₹ Cr)
| Lactose (India) | Wockhardt | Piramal Pharma | Rubicon Research | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
68.58 | 5,343.00 | 10,211.52 | 519.60 | 1,026.85 |
|
Current Assets
|
98.62 | 2,606.00 | 7,191.66 | 1,681.81 | 881.27 |
|
Total Assets
|
133.47 | 8,100.00 | 15,513.53 | 1,451.43 | 1,549.26 |
|
Total Debt*
|
56.22 | 1,859.00 | 4,720.27 | 393.17 | 8.18 |
|
Net Current Assets
|
8.82 | 984.00 | 2,433.38 | 845.94 | 650.46 |
|
Contingent Liabilities
|
7.80 | 770.26 | 99.76 | 12.25 | 15.38 |
Cashflow (₹ Cr)
| Lactose (India) | Wockhardt | Piramal Pharma | Rubicon Research | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.29 | -22.00 | 892.30 | 159.18 | 118.34 |
|
Cash Flow from Investing Activities
|
-15.57 | -783.00 | -477.46 | -64.81 | -223.94 |
|
Cash from Financing Activities
|
18.81 | 409.00 | -440.83 | -39.81 | 261.12 |
|
Net Cash Inflow / Outflow
|
2.95 | -396.00 | -25.99 | 54.56 | 155.52 |
Ratios
Profitability Ratios
| Lactose (India) | Wockhardt | Piramal Pharma | Rubicon Research | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.01 | 4.07 | 6.61 | 26.97 | 20.14 |
|
ROE (%)
|
10.89 | 8.38 | -3.85 | 29.77 | 25.18 |
|
ROA (%)
|
4.38 | 4.94 | -2.21 | 24.77 | 21.93 |
|
EBIT Margin (%)
|
7.86 | 15.32 | 1.66 | 20.63 | 34.54 |
|
Net Margin (%)
|
4.02 | 11.23 | -3.93 | 14.79 | 26.01 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Lactose (India) | Wockhardt | Piramal Pharma | Rubicon Research | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
34.91 | 18.37 | 0.78 | 46.65 | 40.90 |
|
EBIT Growth (%)
|
28.97 | 252.26 | -70.53 | 62.13 | 124.50 |
|
Net Profit Growth (%)
|
57.67 | 377.85 | -1,383.43 | 89.49 | 104.15 |
|
EPS Growth (%)
|
57.67 | 1,001.33 | -484.84 | 78.60 | 42.32 |
|
Book Value Growth (%)
|
10.86 | 29.77 | 2.28 | 42.49 | 94.96 |
Valuation Ratios
| Lactose (India) | Wockhardt | Piramal Pharma | Rubicon Research | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Price / Earnings
|
19.46 | 86.27 | -87.78 | 91.44 | 69.51 |
|
Price / Book Value
|
2.01 | 6.83 | 3.43 | 19.94 | 15.56 |
|
Dividend Yield (%)
|
0.00 | 0.00 | 0.00 | 0.09 | 0.08 |
|
EV/EBITDA
|
9.58 | 46.42 | 31.29 | 59.25 | 49.12 |
|
Market Cap (₹ Cr)
|
111.66 | 23,064.69 | 29,731.27 | 0.00 | 19,988.69 |
Solvency Ratios
| Lactose (India) | Wockhardt | Piramal Pharma | Rubicon Research | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.35 | 0.31 | 0.53 | 0.11 | 0.01 |
|
Short term debt to equity ratio
|
0.40 | 0.11 | 0.12 | 0.54 | 0.02 |
|
Current Ratio
|
1.10 | 1.61 | 1.51 | 2.01 | 3.82 |
|
Quick Ratio
|
0.48 | 1.06 | 0.87 | 1.14 | 2.82 |
|
Interest Coverage
|
2.70 | 3.13 | 0.53 | 10.09 | 141.16 |
Operating Efficiency Ratios
| Lactose (India) | Wockhardt | Piramal Pharma | Rubicon Research | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
19.60 | 16.50 | 23.44 | 26.28 | 24.80 |
|
Asset Turnover
|
1.08 | 0.43 | 0.55 | 1.66 | 0.83 |
|
Receivable days
|
58.07 | 60.36 | 77.05 | 47.59 | 90.06 |
|
Inventory Days
|
64.83 | 64.42 | 77.13 | 62.58 | 61.02 |
|
Payable days
|
67.48 | 218.94 | 173.49 | 228.78 | 96.06 |
|
Cash Conversion Cycle
|
55.42 | -94.15 | -19.30 | -118.62 | 55.02 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
